在COPD老年患者中,与自我管理行为相关的疾病感知:一个横截面研究
Zijun Guo1, Qiao-Hong Yang2, Fan Yang3
1School of Nursing, Sun Yat-sen University, Guangzhou, Guangdong, China.
International journal of nursing practice
|May 15, 2024
概括
患有慢性阻塞性肺病 (COPD) 的老年患者表现出不良的自我管理行为. 疾病的感知显著影响这些行为,这表明未来的COPD自我管理干预措施的目标.
科学领域:
- 老年医学 老年医学
- 肺部病理学 肺部病理学
- 健康心理学 心理健康心理学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性呼吸道疾病,影响着老年人群.
- 有效的自我管理对于管理COPD至关重要,但在老年人中往往仍然不理想.
- 了解患者如何感知疾病及其自我管理行为之间的关系对于有针对性的干预至关重要.
研究的目的:
- 评估老年COPD患者的自我管理行为现状.
- 评估这一患者群体对疾病的看法.
- 研究老年COPD患者的疾病感知和自我管理行为之间的相关性.
主要方法:
- 一项涉及152名被诊断患有COPD的老年患者的横截面研究.
- 使用了COPD自我管理量表和COPD患者的修订疾病感知问卷.
- 采用皮尔森相关性,单变量和层次线性回归分析来探索关系.
主要成果:
- 总体自我管理行为得分为2.90±0.39,信息管理是最低的分级得分 (2.20±0.76).
- 人口统计和临床因素,如教育,吸烟状态,护理人员类型,氧疗法和COPD持续时间,显著影响了自我管理.
- 疾病感知子尺度 (治疗控制,个人控制,连贯性,时间线周期性,身份) 显示在控制共变量后与自我管理行为有显著的相关性.
结论:
- 老年COPD患者的自我管理行为目前不令人满意.
- 在这个人群中,疾病的感知是自我管理行为的重要决定因素.
- 研究结果支持为老年COPD患者开发量身定制的自我管理干预措施,重点关注疾病感知.
更多相关视频
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K